Skip to content
naulon
Not checkedNot checked for notices yet.

Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: case-report and review of the literature

C. Venturin, S. Nancey, P. Danion and 6 more

BMC Gastroenterology · 2017

doi:10.1186/s12876-017-0633-6 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Abstract Background Ustekinumab is a fully human monoclonal antibody against the p40 subunit of interleukin (IL) 12 and 23 which is involved in the pathogenesis of several inflammatory diseases. Ustekinumab is approved for psoriasis and psoriatic arthritis treatment and has been successfully evaluated in phase II and III trials for patients with Crohn’s disease (CD). Case presentation We report here the case of a patient who became pregnant during treatment with ustekinumab for a refractory CD and which ended in miscarriage. Conclusion Ustekinumab is a relatively new pharmacotherapy and in addition to this clinical case, we reviewed the published literature concerning the use of this treatment during pregnancy and its consequences on pregnancy and fetus outcome.

Abstract licence: CC BY-NC-ND

Cited by papers we hold1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.